Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on July 10, 2009
JNCI Journal of the National Cancer Institute 2009 101(16):1156-1157; doi:10.1093/jnci/djp199
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
101/16/1156-a    most recent
djp199v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Wolpin, B. M.
Right arrow Articles by Fuchs, C. S.
PubMed
Right arrow Articles by Wolpin, B. M.
Right arrow Articles by Fuchs, C. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press.

CORRESPONDENCE

Response: Re: ABO Blood Group and the Risk of Pancreatic Cancer

Brian M. Wolpin, Charles S. Fuchs

Affiliation of authors: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA (BMW, CSF)

Correspondence to: Brian M. Wolpin, MD, MPH, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115 (e-mail: bwolpin@partners.org).

The first 10% of the full text of this article appears below.

We appreciate the comments of Dr Maisonneuve et al. (1). They highlighted an interesting biology relating to ABO blood group antigens, namely, . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?